GLP-1RA and SGLT2i utilization in people with type 2 diabetes with atherosclerotic cardiovascular disease (ASCVD) or at high risk of ASCVD in the Gulf Region: Results from the PACT-MEA studys
海湾地区患有动脉粥样硬化性心血管疾病 (ASCVD) 或 ASCVD 高风险的 2 型糖尿病患者中 GLP-1RA 和 SGLT2i 的使用情况：PACT-MEA 研究的结果
期刊:Saudi Medical Journal
影响因子:1.5
doi:10.15537/smj.2025.46.2.20240620
Al-Dahi, Waleed A; Khalaf, Saeed H; AlRomaihi, Dalal A; Alamuddin, Naji M; Al Kandari, Hessa M; Abdalla, Doaa K; Alfadehla, Hanan Y; Jayyousi, Amin A; Siddique, Mashhood A; AlAlami, Usama A; Subbarao, Guruprasad C; Chetty, Shashikanth J; Abdulla, Jehan A
SGLT2
GLP-1
心血管疾病
心血管
代谢
ASC
糖尿病
动脉粥样硬化
